DPA
GILD icon

Delphi Private Advisors’s Gilead Sciences GILD Stock Holding History

Delphi Private Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,276
Closed -$91K – 98
2017
Q4 		$91K Buy
+1,276
New +$96.9K 0.22% 40
2017
Q1 		– Sell
-127
Closed -$9K – 181
2016
Q4 		$9K Sell
127
-67
-35% -$4.98K 0.02% 106
2016
Q3 		$15K Sell
194
-200
-51% -$16.2K 0.03% 80
2016
Q2 		$33K Buy
394
+58
+17% +$5.15K 0.06% 57
2016
Q1 		$31K Sell
336
-226
-40% -$20.4K 0.06% 67
2015
Q4 		$57K Buy
+562
New +$58.5K 0.1% 45

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Delphi Private Advisors's GILD Position: Q1 2018 in Review

Delphi Private Advisors sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 1,276 shares — an estimated $91K sold.

Delphi Private Advisors first reported a position in GILD in Q4 2015 and held it in 6 quarters. The position peaked at $91K in Q4 2017. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • Delphi Private Advisors reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
  • Delphi Private Advisors sold 1,276 Gilead Sciences shares in Q1 2018, an estimated $91K.
  • Delphi Private Advisors first reported a position in Gilead Sciences in Q4 2015 and held it in 6 quarters.
  • Delphi Private Advisors's Gilead Sciences position peaked at $91K in Q4 2017.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Delphi Private Advisors's 13F filing for Q1 2018, filed 2 May 2018.